- Conditions
- Conscious Sedation
- Interventions
- AQUAVAN® (fospropofol disodium) Injection, Midazolam HCI
- Drug
- Lead sponsor
- Eisai Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006
- U.S. locations
- 20
- States / cities
- Huntsville, Alabama • Fresno, California • Jacksonville, Florida + 17 more
Source: ClinicalTrials.gov public record
Updated Nov 6, 2008 · Synced May 22, 2026, 5:05 AM EDT